Chemicals · Founded 1938 · www.polsonltd.com · BSE 507645 · · ISIN INE339F01021
No Notes Added Yet
Business
Polson Ltd. operates within the chemicals sector, specifically focusing on the manufacturing and sale of basic inorganic chemical products. Historically, the company has had a diversified business portfolio, but within the chemical segment, it primarily produces industrial chemicals such as Sodium Sulphate Anhydrous and Decahydrate (Glauber's Salt). The company makes money by supplying these chemicals as raw materials to various industrial customers across sectors like detergents, glass, paper, and textiles.
Revenue Mix
While Polson Ltd. has diversified interests including real estate and investments, its chemical segment's primary revenue generation is from the sale of basic inorganic chemicals like Sodium Sulphate. Precise, detailed revenue contribution percentages for its chemical operations relative to its other businesses are generally not the majority of its overall revenue. However, within the chemical operations, the focus is concentrated on a narrow range of industrial salts.
Industry
The Indian chemicals industry is large and diverse. Polson Ltd. operates in the basic inorganic chemicals sub-segment, which is a mature and often commoditized part of the industry. In this landscape, the company is likely a niche or smaller-scale player, serving specific industrial demands rather than having a broad market presence across various chemical categories. It competes with both larger, integrated chemical manufacturers and other specialized producers of industrial salts.
MOAT
Polson Ltd.'s competitive advantages in the basic chemicals market appear limited.
Scale/Cost: Being a smaller player, achieving significant cost leadership through scale is challenging.
Switching Costs: For basic commodity chemicals, switching costs for industrial buyers are typically low.
Brand: While Polson has a historical brand in India, it lacks a strong, direct brand moat in the B2B chemical ingredients market.
Any potential moat might lie in long-standing customer relationships or specific process efficiencies for its narrow product range, but these are generally considered weaker moats in a commoditized industry.
Growth Drivers
Industrial Demand: Growth in key end-user industries in India (e.g., detergents, glass, paper, textiles) will directly drive demand for its basic chemical products.
Economic Expansion: Overall industrial and manufacturing sector growth in India can create increased demand for essential raw materials like industrial salts.
Operational Efficiency: Optimizing existing production processes and improving capacity utilization can enhance profitability without significant capacity expansion.
Potential Diversification within Chemicals: Strategic expansion into related or higher-value chemical derivatives, if pursued, could unlock new growth avenues.
Risks
Commodity Price Volatility: Fluctuations in raw material costs and end-product prices, driven by global supply-demand dynamics, can significantly impact margins.
Intense Competition: The basic chemicals segment faces stiff competition from larger domestic and international players, leading to pricing pressure.
Regulatory Environment: Strict environmental, health, and safety regulations for chemical manufacturing and handling can increase compliance costs.
Technological Obsolescence/Substitutes: Changes in manufacturing processes in end-user industries or the development of substitute materials could reduce demand.
Economic Downturn: A slowdown in the Indian economy or specific end-user industries could directly depress demand for its products.
Diversion of Focus: The company's diversified interests in real estate and investments could potentially dilute strategic focus and capital allocation for its chemical business.
Management & Ownership
Polson Ltd. is a promoter-driven company, with a significant ownership stake typically held by the founding family or associated entities. This structure often implies a long-term perspective but also centralized control. Public shareholders hold the remaining stake. The quality of management's strategic vision and execution for the chemical segment, separate from their other ventures, would need to be assessed through recent financial reports and corporate governance disclosures.
Outlook
Polson Ltd.'s outlook within the chemicals sector is characterized by its position as a niche player in basic inorganic chemicals.
Bull Case: The company could benefit from sustained growth in India's industrial economy, leading to steady demand for its products. If management enhances operational efficiencies, focuses on specific customer needs, and potentially makes measured investments to diversify within the chemical value chain, it could achieve stable profits and modest growth.
Bear Case: As a smaller entity in a commodity market, Polson Ltd. faces inherent challenges from price volatility, strong competition, and limited pricing power. Without substantial strategic investment and a clear, differentiated chemical business strategy, its growth prospects in this segment might remain constrained, with its chemical operations potentially generating only modest returns amidst broader corporate diversification.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 24 | 25 | 21 | 23 | 25 | 24 | 22 | 22 | 24 | 28 |
| Other Income | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 |
| Total Income | 25 | 25 | 21 | 23 | 26 | 24 | 22 | 23 | 24 | 29 |
| Total Expenditure | 21 | 21 | 17 | 19 | 21 | 20 | 18 | 18 | 20 | 24 |
| Operating Profit | 3 | 4 | 4 | 4 | 5 | 4 | 4 | 4 | 4 | 5 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Provision for Tax | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 |
| Profit After Tax | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Adjustments | -0 | -0 | 0 | -0 | -0 | -0 | 0 | -0 | -0 | 0 |
| Profit After Adjustments | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Adjusted Earnings Per Share | 45.6 | 119.3 | 95.8 | 104 | 116.9 | 102.4 | 101.8 | 101.1 | 90 | 133.8 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 104 | 104 | 108 | 106 | 109 | 97 | 89 | 98 | 84 | 96 | 93 | 96 |
| Other Income | 7 | 7 | 5 | 4 | 6 | 5 | 4 | 3 | 2 | 1 | 2 | 1 |
| Total Income | 111 | 111 | 113 | 110 | 115 | 102 | 93 | 100 | 86 | 98 | 95 | 98 |
| Total Expenditure | 92 | 89 | 89 | 87 | 93 | 81 | 73 | 82 | 70 | 81 | 78 | 80 |
| Operating Profit | 19 | 22 | 24 | 23 | 22 | 21 | 20 | 18 | 16 | 17 | 17 | 17 |
| Interest | 8 | 9 | 7 | 7 | 7 | 6 | 6 | 4 | 6 | 4 | 4 | 4 |
| Depreciation | 2 | 3 | 3 | 4 | 4 | 5 | 5 | 5 | 6 | 6 | 6 | 8 |
| Exceptional Income / Expenses | 0 | 15 | 1 | 6 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Profit Before Tax | 10 | 25 | 16 | 18 | 11 | 10 | 9 | 9 | 7 | 7 | 7 | 8 |
| Provision for Tax | 3 | 9 | 6 | 7 | 1 | 3 | 1 | 2 | 2 | 2 | 2 | 2 |
| Profit After Tax | 7 | 16 | 10 | 11 | 10 | 7 | 9 | 6 | 5 | 5 | 5 | 5 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 7 | 16 | 10 | 11 | 10 | 7 | 9 | 6 | 5 | 5 | 5 | 5 |
| Adjusted Earnings Per Share | 545.6 | 1346.1 | 860.5 | 909.5 | 827.3 | 591.5 | 711 | 519.1 | 402.5 | 433.1 | 435.9 | 426.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -3% | -2% | -1% | -1% |
| Operating Profit CAGR | 0% | -2% | -4% | -1% |
| PAT CAGR | 0% | -6% | -7% | -3% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -14% | -7% | -5% | 2% |
| ROE Average | 4% | 4% | 5% | 11% |
| ROCE Average | 7% | 7% | 8% | 12% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 46 | 62 | 70 | 81 | 91 | 96 | 105 | 111 | 116 | 122 | 127 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 61 | 48 | 41 | 48 | 43 | 40 | 28 | 21 | 17 | 14 | 26 |
| Other Non-Current Liabilities | 1 | 4 | 9 | 11 | 9 | 10 | 8 | 8 | 8 | 9 | 9 |
| Total Current Liabilities | 73 | 41 | 45 | 40 | 40 | 38 | 31 | 52 | 39 | 36 | 27 |
| Total Liabilities | 180 | 154 | 164 | 180 | 182 | 184 | 172 | 192 | 181 | 180 | 189 |
| Fixed Assets | 83 | 86 | 83 | 93 | 98 | 95 | 99 | 108 | 114 | 117 | 120 |
| Other Non-Current Assets | 36 | 21 | 27 | 21 | 19 | 30 | 30 | 30 | 21 | 22 | 32 |
| Total Current Assets | 61 | 48 | 53 | 66 | 65 | 60 | 42 | 53 | 45 | 40 | 36 |
| Total Assets | 180 | 154 | 164 | 180 | 182 | 184 | 172 | 192 | 181 | 180 | 189 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 5 | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 4 | 0 | 1 |
| Cash Flow from Operating Activities | 19 | 35 | 19 | 6 | 11 | 32 | 22 | 2 | 12 | 25 | 17 |
| Cash Flow from Investing Activities | -46 | -0 | -9 | -11 | 0 | -22 | 3 | -9 | -0 | -10 | -19 |
| Cash Flow from Financing Activities | 23 | -34 | -11 | 5 | -12 | -10 | -25 | 10 | -15 | -15 | 2 |
| Net Cash Inflow / Outflow | -4 | 1 | -0 | 0 | -0 | -0 | 1 | 3 | -3 | 0 | 0 |
| Closing Cash & Cash Equivalent | 1 | 2 | 1 | 1 | 0 | 0 | 1 | 4 | 0 | 1 | 1 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 545.64 | 1346.09 | 860.48 | 909.46 | 827.33 | 591.52 | 710.99 | 519.12 | 402.46 | 433.09 | 435.91 |
| CEPS(Rs) | 725.27 | 1600.79 | 1131.69 | 1216.29 | 1162.42 | 968.65 | 1108.53 | 946.84 | 861.71 | 911.92 | 940.57 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 3766.97 | 5113.06 | 5805.21 | 6725.13 | 7553.36 | 8019.25 | 8730.82 | 9191.86 | 9625.8 | 10099.11 | 10532.55 |
| Core EBITDA Margin(%) | 11.88 | 14.5 | 17.62 | 17.37 | 14.85 | 16.67 | 17.63 | 15.93 | 17.02 | 16.4 | 15.95 |
| EBIT Margin(%) | 16.5 | 32.57 | 20.68 | 23.45 | 16.77 | 17.49 | 16.76 | 13.48 | 14.54 | 11.81 | 11.59 |
| Pre Tax Margin(%) | 9.22 | 24.2 | 14.65 | 17.11 | 10.42 | 10.77 | 10.32 | 8.9 | 7.93 | 7.6 | 7.65 |
| PAT Margin (%) | 6.3 | 15.51 | 9.54 | 10.32 | 9.11 | 7.34 | 9.63 | 6.39 | 5.76 | 5.39 | 5.61 |
| Cash Profit Margin (%) | 8.38 | 18.44 | 12.54 | 13.8 | 12.8 | 12.02 | 15.01 | 11.65 | 12.33 | 11.35 | 12.1 |
| ROA(%) | 4.41 | 9.67 | 6.49 | 6.35 | 5.49 | 3.88 | 4.8 | 3.43 | 2.59 | 2.88 | 2.84 |
| ROE(%) | 15.62 | 30.32 | 15.76 | 14.52 | 11.59 | 7.6 | 8.49 | 5.79 | 4.28 | 4.39 | 4.23 |
| ROCE(%) | 14.66 | 25.64 | 17.16 | 17.26 | 11.61 | 10.53 | 9.53 | 8.21 | 7.28 | 7.03 | 6.58 |
| Receivable days | 55.51 | 74.27 | 90.9 | 90.15 | 83.3 | 90.74 | 83.34 | 59.47 | 55.78 | 49.39 | 50.55 |
| Inventory Days | 52.18 | 27.79 | 17.42 | 41.45 | 59.37 | 54.95 | 36.13 | 67.63 | 122.81 | 90.31 | 71.86 |
| Payable days | 83.98 | 95.68 | 90.79 | 101.68 | 83.68 | 99.1 | 129.35 | 112.24 | 84.02 | 69.48 | 91.33 |
| PER(x) | 11.2 | 5.47 | 12.86 | 16.54 | 13.17 | 11.69 | 12.9 | 21.27 | 24.76 | 29.2 | 27.51 |
| Price/Book(x) | 1.62 | 1.44 | 1.91 | 2.24 | 1.44 | 0.86 | 1.05 | 1.2 | 1.04 | 1.25 | 1.14 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 1.57 | 1.47 | 1.75 | 2.26 | 1.76 | 1.35 | 1.68 | 1.92 | 2.01 | 1.96 | 1.99 |
| EV/Core EBITDA(x) | 8.45 | 6.92 | 7.84 | 10.46 | 8.59 | 6.11 | 7.59 | 10.24 | 10.23 | 11.01 | 11 |
| Net Sales Growth(%) | 7.12 | 0.23 | 3.96 | -2.32 | 3 | -11.24 | -8.36 | 10.06 | -14.02 | 14.95 | -3.23 |
| EBIT Growth(%) | 22.65 | 97.82 | -33.98 | 10.74 | -26.34 | -7.44 | -12.16 | -11.47 | -7.26 | -6.62 | -5.06 |
| PAT Growth(%) | 51.85 | 146.7 | -36.08 | 5.69 | -9.03 | -28.5 | 20.2 | -26.99 | -22.47 | 7.61 | 0.65 |
| EPS Growth(%) | 51.85 | 146.7 | -36.08 | 5.69 | -9.03 | -28.5 | 20.2 | -26.99 | -22.47 | 7.61 | 0.65 |
| Debt/Equity(x) | 2.01 | 1.1 | 0.9 | 0.92 | 0.76 | 0.68 | 0.43 | 0.54 | 0.43 | 0.31 | 0.34 |
| Current Ratio(x) | 0.83 | 1.17 | 1.2 | 1.63 | 1.64 | 1.58 | 1.35 | 1.02 | 1.16 | 1.14 | 1.34 |
| Quick Ratio(x) | 0.66 | 1.1 | 1.04 | 1.22 | 1.16 | 1.3 | 1.13 | 0.46 | 0.45 | 0.57 | 0.73 |
| Interest Cover(x) | 2.26 | 3.89 | 3.43 | 3.7 | 2.64 | 2.6 | 2.6 | 2.94 | 2.2 | 2.8 | 2.94 |
| Total Debt/Mcap(x) | 1.24 | 0.76 | 0.47 | 0.41 | 0.53 | 0.79 | 0.41 | 0.45 | 0.41 | 0.25 | 0.3 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 |
| Public | 24.81 | 24.81 | 24.81 | 24.81 | 24.81 | 24.81 | 24.81 | 24.81 | 24.81 | 24.81 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -3% | -2% | -1% | -1% |
| Operating Profit CAGR | 0% | -2% | -4% | -1% |
| PAT CAGR | 0% | -6% | -7% | -3% |
| Share Price CAGR | -14% | -7% | -5% | +2% |
| ROE Average | +4% | +4% | +5% | +11% |
| ROCE Average | +7% | +7% | +8% | +12% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 | 74.98 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 |
| Public | 24.81 | 24.81 | 24.81 | 24.81 | 24.81 | 24.81 | 24.81 | 24.81 | 24.81 | 24.81 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.